Search Results 321-330 of 17128 for nivolumab
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line ...
The purpose of this study is to determine how well cabozantinib and nivolumab work in treating patients with endometrial cancer that has come back or spread to ...
In-home Versus In-Clinic Subcutaneous Nivolumab Administration Through Connected And Remote Cancer CARE Beyond Walls. Jacksonville, Fla. The purpose of this ...
... nivolumab in patients with solid tumors that have spread and/or cannot be removed by surgery. The following tumor types are included in this study: Non ...
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. Melanoma In-transit Tissue Bank and Molecular Analysis for Personalized ...
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing ...
The purpose of this study is to determine whether Nivolumab, in combination with brentuximab vedotin, is safe and effective in patients with certain subtypes of ...
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) ... nivolumab in each disease cohort, both across and within tumor biomarker subgroups.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!